About Merial
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.
Merial employs approximately 5,600 people and operates in more than 150 countries worldwide.
Its 2011 sales were more than €2 billion ($2.8 billion).
Committed to innovation and research, Merial has instigated the setting up of the Merial Cancer Board.
The Merial Cancer Board is a collaborative group of European experts investigating the role of COX-2 in cancer.
Merial is a Sanofi company. For more information, please see www.merial.com.
Pfizer Animal Health is dedicated to transforming the care of animals—both companion and livestock species—for a healthier world.
We have operations in more than 60 countries, with leading market positions across four geographic regions: the United States; Europe, Africa & the Middle East; Canada & Latin America; and Asia-Pacific.
Additionally, we have an extensive global R&D network—with major research centers on four continents.
Globally, we have more than 5,000 Pfizer Animal Health colleagues, including 700 scientists, veterinarians and specialists.
AB Science:
Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of novel targeted therapies for patients with cancer and other significant unmet medical needs including inflammatory and central nervous system diseases. AB Science has developed a proprietary portfolio of protein kinase inhibitors (PKIs), a new class of targeted molecules whose action is to modify signaling pathways within cells.
AB Science’s lead product, masitinib, has already been registered in veterinary medicine in Europe (Masivet ®) and the US (Kinavet®), and is currently in 9 phase 3 human studies, including 8 studies on-going in pancreatic cancer, GIST, metastatic melanoma, multiple myeloma, mastocytosis, severe persistent asthma, rheumatoid arthritis, and progressive multiple sclerosis.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com